D-0078-2023 Class II Terminated

Recalled by OurPharma LLC — Fayetteville, AR

FDA drug recall D-0078-2023 was initiated by OurPharma LLC on Nov 29, 2022 and is designated Class II. Reason for recall: Underfilled units. The recall status is terminated (terminated Sep 20, 2024). Affected quantity: 691 cassettes.

Recall details

Product Type
Drugs
Report Date
Dec 21, 2022
Initiation Date
Nov 29, 2022
Termination Date
Sep 20, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
691 cassettes

Product description

FentaNYL Citrate 2.5 mg/50 mL (50mcg/ml) Injection Solution, Preservative Free, Single Use 50 ml Cassette, Rx Only, Repackaged by OurPharma, LLC. 2512 S. City Lake Rd. Fayetteville, AR 72701, 1-833-290-2654, NDC 73013-001-01

Reason for recall

Underfilled units.

Distribution pattern

MO

Code information

Lots: 100122060007 Exp. 12/17/2022; 100122060008 Exp. 12/18/2022; 100122070002 Exp. 01/09/2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0078-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0078-2023. Report a data issue: hello@regdatalab.com.